These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 19345559)
21. The recent saga of cardiovascular disease and safety of oral contraceptives. Edwards RG; Cohen J Hum Reprod Update; 1999; 5(6):565-620. PubMed ID: 10652970 [TBL] [Abstract][Full Text] [Related]
22. [Oral contraceptives--risk factors for cardiovascular events--chance association or causal relation?]. Marmot M; Heinemann L Z Arztl Fortbild (Jena); 1988; 82(2):57-63. PubMed ID: 3284213 [No Abstract] [Full Text] [Related]
27. Evaluation of mifepristone as a once a month contraceptive pill. Agarwal M; Das V; Agarwal A; Pandey A; Srivastava D Am J Obstet Gynecol; 2009 May; 200(5):e27-9. PubMed ID: 19026402 [TBL] [Abstract][Full Text] [Related]
28. [Mortality in women of reproductive age due to diseases of the circulatory system caused by the use of oral contraceptives in Yugoslavia]. Ananijević-Pandey J; Vlajinac H Acta Med Iugosl; 1983; 37(3):185-95. PubMed ID: 6637576 [No Abstract] [Full Text] [Related]
29. [Report from the Danish Board on Adverse Reactions. 13. Reports on adverse reactions with use of oral contraceptives during the period 1 May 1968-1 November 1970]. Ugeskr Laeger; 1971 Feb; 133(5):211-4. PubMed ID: 5100740 [No Abstract] [Full Text] [Related]
30. Mortality associated with the pill. Lancet; 1977 Nov; 2(8046):1023-4. PubMed ID: 72914 [No Abstract] [Full Text] [Related]
31. Letter: Acanthosis nigricans following use of oral contraceptives. Curth HO Arch Dermatol; 1975 Aug; 111(8):1069. PubMed ID: 1232930 [No Abstract] [Full Text] [Related]
32. [Risk and benefits of using contraceptives of third generation]. Uchikova E; Milchev N Akush Ginekol (Sofiia); 2004; 43(1):59-62. PubMed ID: 15168658 [No Abstract] [Full Text] [Related]
33. [Possible interference of synthetic estroprogestins with thyroid hormone production]. Paggi A; Leri O; Evangelista M; Manfredi F; Coarelli C; Loiacono C; Cassone R Clin Ter; 1981 Aug; 98(4):349-63. PubMed ID: 7285541 [No Abstract] [Full Text] [Related]
36. [Neurologic complications after oral contraceptives]. Orzechowska M; Poźniak-Patewicz E; Rosset SO Wiad Lek; 1970 Dec; 23(24):2199-201. PubMed ID: 5532005 [No Abstract] [Full Text] [Related]
37. Taking the long view. Aschwanden C Sci Aging Knowledge Environ; 2004 Jun; 2004(26):ns3. PubMed ID: 15229346 [No Abstract] [Full Text] [Related]
38. The risk of cardiovascular disease with second- and third-generation oral contraceptives. Kovacs P Medscape Womens Health; 2002; 7(4):3. PubMed ID: 12466735 [No Abstract] [Full Text] [Related]
39. [Cerebrovascular complications following intake of oral contraceptives (review of the literature apropos of a case]. Bouraoui K; Courtois G Union Med Can; 1980 Feb; 109(2):284-8. PubMed ID: 6998073 [No Abstract] [Full Text] [Related]
40. [Incidence distribution of the so-called risk factors among ovulation inhibitors]. Ravens KG; Doré G; Jipp P Verh Dtsch Ges Inn Med; 1975; 81():1725-7. PubMed ID: 1227069 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]